<?xml version="1.0"?>
<oembed><version>1.0</version><provider_name>Breakthrough T1D</provider_name><provider_url>https://breakthrought1d.eu/nl</provider_url><author_name>ylt-admin</author_name><author_url>https://breakthrought1d.eu/nl/nieuws/author/ylt-admin/</author_url><title>Onderzoek naar liraglutide - Breakthrough T1D</title><type>rich</type><width>600</width><height>338</height><html>&lt;blockquote class="wp-embedded-content" data-secret="wawH1p3uRS"&gt;&lt;a href="https://breakthrought1d.eu/nl/nieuws/onderzoek-naar-liraglutide/"&gt;Onderzoek naar liraglutide&lt;/a&gt;&lt;/blockquote&gt;&lt;iframe sandbox="allow-scripts" security="restricted" src="https://breakthrought1d.eu/nl/nieuws/onderzoek-naar-liraglutide/embed/#?secret=wawH1p3uRS" width="600" height="338" title="&#x201C;Onderzoek naar liraglutide&#x201D; &#x2014; Breakthrough T1D" data-secret="wawH1p3uRS" frameborder="0" marginwidth="0" marginheight="0" scrolling="no" class="wp-embedded-content"&gt;&lt;/iframe&gt;&lt;script&gt;
/*! This file is auto-generated */
!function(d,l){"use strict";l.querySelector&amp;&amp;d.addEventListener&amp;&amp;"undefined"!=typeof URL&amp;&amp;(d.wp=d.wp||{},d.wp.receiveEmbedMessage||(d.wp.receiveEmbedMessage=function(e){var t=e.data;if((t||t.secret||t.message||t.value)&amp;&amp;!/[^a-zA-Z0-9]/.test(t.secret)){for(var s,r,n,a=l.querySelectorAll('iframe[data-secret="'+t.secret+'"]'),o=l.querySelectorAll('blockquote[data-secret="'+t.secret+'"]'),c=new RegExp("^https?:$","i"),i=0;i&lt;o.length;i++)o[i].style.display="none";for(i=0;i&lt;a.length;i++)s=a[i],e.source===s.contentWindow&amp;&amp;(s.removeAttribute("style"),"height"===t.message?(1e3&lt;(r=parseInt(t.value,10))?r=1e3:~~r&lt;200&amp;&amp;(r=200),s.height=r):"link"===t.message&amp;&amp;(r=new URL(s.getAttribute("src")),n=new URL(t.value),c.test(n.protocol))&amp;&amp;n.host===r.host&amp;&amp;l.activeElement===s&amp;&amp;(d.top.location.href=t.value))}},d.addEventListener("message",d.wp.receiveEmbedMessage,!1),l.addEventListener("DOMContentLoaded",function(){for(var e,t,s=l.querySelectorAll("iframe.wp-embedded-content"),r=0;r&lt;s.length;r++)(t=(e=s[r]).getAttribute("data-secret"))||(t=Math.random().toString(36).substring(2,12),e.src+="#?secret="+t,e.setAttribute("data-secret",t)),e.contentWindow.postMessage({message:"ready",secret:t},"*")},!1)))}(window,document);
//# sourceURL=https://breakthrought1d.eu/nl/wp-includes/js/wp-embed.min.js
&lt;/script&gt;
</html><description>Onderzoekers van de University of Buffalo starten een vervolg-onderzoek naar de effectiviteit van het middel liraglutide bij T1D. De werkzaamheid van liraglutide bij T2D is al onderzocht en lijkt te berusten op verhogen van de insuline productie in de alvleesklier. OP grond daarvan werd aangenomen dat het middel bij T1D niet erg effectief zou zijn, [&hellip;]</description></oembed>
